Background: Conventional magnetic resonance (MR) imaging has a number of limitations in the diagnosis of the most common intracranial brain tumors, including tumor specification and the detection of tumoral infiltration in regions of peritumoral edema. Purpose: To prospectively assess if diffusion-weighted MR imaging (DWI) could be used to differentiate between different types of brain tumors and to distinguish between peritumoral infiltration in high-grade gliomas, lymphomas, and pure vasogenic edema in metastases and meningiomas. Material and Methods: MR imaging and DWI was performed on 93 patients with newly diagnosed brain tumors: 59 patients had histologically verified high-grade gliomas (37 glioblastomas multiforme, 22 anaplastic astrocytomas), 23 patients had metastatic brain tumors, five patients had primary cerebral lymphomas, and six patients had meningiomas. Apparent diffusion coefficient (ADC) values of tumor (enhancing regions or the solid portion of tumor) and peritumoral edema, and ADC ratios (ADC of tumor or peritumoral edema to ADC of contralateral white matter, ADC of tumor to ADC of peritumoral edema) were compared with the histologic diagnosis. ADC values and ratios of high-grade gliomas, primary cerebral lymphomas, metastases, and meningiomas were compared by using ANOVA and multiple comparisons. Optimal thresholds of ADC values and ADC ratios for distinguishing high-grade gliomas from metastases were determined by receiver operating characteristic (ROC) curve analysis. Results: Statistically significant differences were found for minimum and mean of ADC tumor and ADC tumor ratio values between metastases and high-grade gliomas when including only one factor at a time. Including a combination of in total four parameters (mean ADC tumor, and minimum, maximum and mean ADC tumor ratio) resulted in sensitivity, specificity, positive (PPV), and negative predictive values (NPV) of 72.9, 82.6, 91.5, and 54.3% respectively. In the ROC curve analysis, the area under the curve of the combined four parameters was the largest (0.84), indicating a good test. Conclusion: Our results suggest that ADC values and ADC ratios (minimum and mean of ADC tumor and ADC tumor ratio) may be helpful in the differentiation of metastases from high-grade gliomas. It cannot distinguish high-grade gliomas from lymphomas, and lymphomas from metastases. ADC values and ADC ratios in peritumoral edema cannot be used to differentiate edema with infiltration of tumor cells from vasogenic edema when measurements for high-grade gliomas, lymphomas, metastases, and meningiomas were compared.
Diffusion-weighted MR imaging (DWI) is being incorporated into standard clinical evaluation of brain tumors. DWI is a technique in which phasedefocusing and phase-refocusing gradients allow evaluation of microscopic water diffusion within tissues. Apparent diffusion coefficient (ADC) can be calculated from diffusion-weighted images.
The presence of an inverse correlation between tumor cellularity and tumor ADC measurement raises the possibility that tumor ADC measurement may be helpful in distinguishing tumors with relatively low cellularity from other lesions (1) . ADC maps generated from DWI have proved useful in defining solid enhancing tumor, noncontrast enhancing lesion, peritumoral edema, and necrotic or cystic regions from normal parenchyma (2Á4), but there are also several examples to the contrary (5Á7).
Our prospective investigation aimed to assess whether ADC values and ratios in the tumoral core could be used to differentiate different brain tumors, and to determine whether the ADC values and ratios in peritumoral edema can distinguish combined tumor infiltration and vasogenic edema around gliomas and lymphomas from pure vasogenic edema around metastases and meningiomas.
Material and Methods

Patients and histopathological analysis
Magnetic resonance (MR) imaging and DWI were performed on 93 patients with newly diagnosed brain tumors immediately before undergoing surgical resection at our institution. Patients had no clinical history of previous surgery, chemotherapy, or radiotherapy.
A total of 59 patients (mean age 9 SD 61 9 14 years, median age 61 years, age range 25Á88 years) had histologically verified high-grade gliomas (37 glioblastomas multiforme and 22 anaplastic astrocytomas) according to the classification of the World Health Organization (8) . Twenty-three patients (mean age 9 SD 64914 years, median age 69 years, age range 30Á85 years) had histologically verified metastatic brain tumors, including six melanomas, nine lung carcinomas, three colon carcinomas, one breast cancer, one urinary bladder carcinoma, and three with unknown primary site. Five patients (mean age 9 SD 62 9 8 years, median age 63 years, age range 51Á73 years) had histologically verified primary cerebral lymphomas. Six patients (mean age 9 SD 59 9 5 years, median age 57 years, age range 55Á66 years) had histologically verified meningiomas.
Informed consent was obtained from all subjects before the study using a protocol approved by our regional ethics committee.
Magnetic resonance (MR) imaging and diffusion-weighted MR imaging (DWI)
The examinations were performed on a 1.5T MR imaging unit (Magnetom Sonata; Siemens, Erlangen, Germany). The MR imaging protocol consisted of T1-weighted spin-echo (SE) images, T2-weighted turbo SE and fluid-attenuated inversion-recovery (FLAIR) sequences. T1-weighted sequence was performed in the transverse plane with the following parameters: TR/TE 500/7.7 ms, field of view (FOV) 270 mm, matrix size 144)256, slice thickness 5 mm, intersection gap 1, averages 2. The T2-weighted turbo SE was performed in the transverse plane with TR/TE 4650/79 ms, FOV 230 mm, matrix size 192)256, slice thickness 5 mm, intersection gap 1 mm, averages 2. FLAIR sequence was performed in the transverse plane with TR/TE/TI 8500/117/2500 ms, FOV 230 mm, matrix size 147)256, slice thickness 4 mm, intersection gap 0.6 mm, averages 2. After contrast medium injection (Magnevist; Bayer Schering Pharma, Berlin, Germany), a magnetization prepared rapid acquisition gradient echo (MPRAGE) T1-weighted sequence was acquired with the following parameters: TR/TE 1900/4.38 ms, FOV 230 mm, matrix size 256)256, slice thickness 1 mm, averages 1.
DWI was performed before administration of contrast medium in the transverse plane by using a single-shot SE echo-planar sequence with the following parameters: TR/TE 3100/96 ms, matrix size 128)128, FOV 211 mm, slice thickness 5 mm, intersection gap 1.5 mm; diffusion gradient encoding in three orthogonal directions (x, y and, z axes) at b values of 0, 500, and 1000 s/mm 2 . From these data, ADC maps and values were calculated on a pixel-by-pixel basis by using a Syngo workstation (Siemens, Erlangen, Germany) operating with the regions of interest (ROIs).
Diffusion-weighted MR imaging (DWI) data evaluation
Round-shaped ROIs (area 0.14 cm 2 , 5 pixels) were placed over three areas within the tumors (ADCt) corresponding to the enhancing region or the solid portion of tumor (non-enhancing tumors), in three areas with peritumoral edema (ADCe) corresponding to a region adjacent to the tumoral area (hyperintense on T2-weighted images, but no enhancing on postcontrast T1-weighted images), and in three areas in contralateral normal-appearing white matter (ADCn). Then the minimum, the maximum and the mean of ADCt, ADCe, and ADCn were selected for analysis (Fig. 1) .
ADC ratios were calculated by dividing the value in either the tumor or in the peritumoral edema by the value in the contralateral normal-appearing white matter (ADCt ratio and ADCe ratio, respectively), and by dividing the value in the tumor by the value in the peritumoral edema (ADCt/e ratio). Then the minimum, the maximum and the mean of ADCt ratio, ADCe ratio, and ADCt/e ratio were selected for analysis. The ROIs values were expressed as 10 (3 mm 2 /s. The ROIs were carefully placed to avoid cystic, necrotic, and hemorrhagic regions that might influence ADC values. The ADC values in our study represent averaged ADCs of three ROIs. The neuroradiologist placing the ROIs was blinded to the tumor histology.
Statistical analysis
ANOVA was used to calculate whether the four tumor groups (high-grade gliomas, metastatic brain tumors, primary cerebral lymphomas, and meningiomas) showed significant differences according to the different ADC values and ratios or not. The significance threshold was set to nominal 20% for variable selection purposes. For further investigation of the pairwise differences of the significant ADC values, Tukey's T-procedure for multiple comparison was used together with the Westfall adjustment method. This was done on a significance level of 5%.
Receiver operating characteristic (ROC) curve analyses based on logistic regression models was performed in order to identify the optimal ADC value or ADC value combination for prediction purposes. The multifactorial logistic regression was done step-wise by taking the area under the curve (AUC), Akaikes information criterion (AIC) and significance of the interesting factors as criteria. Sensitivity, specificity, positive (PPV), and negative predictive values (NPV) as well as accuracy are reported for the optimal thresholds.
All analyses were carried out by using the software package R (9).
Results
All values including the tumor values (minimum, maximum and mean of ADCt, ADCt ratio, and ADCt/e ratio) differed significantly between the four tumor types (all corresponding P-values B0.2, ANOVA) on a nominal level (Table 1) .
Testing for pairwise differences between the four tumor types lead to four significant differences: minimum ADCt value, mean ADCt value, minimum ADCt ratio, and mean ADCt ratio between metastases and high-grade gliomas (all P-values B5%, multiple comparisons with Tukey's test and Westfall adjustment). The maximum ADCt value and maximum ADCt ratio were taken into further account as well, since the P-values were borderline (P00.063 and P00.069, respectively, Table 2 ). The ADCt/e ratios were excluded from further analysis since they clearly exceeded the given significance threshold. ROC analyses for each ADC-value as a single factor, found the minimum ADCt ratio to be the best predictive indicator. The AUC of this quantitative parameter was 0.73. The optimal cut-off value for differentiating high-grade gliomas from metastases was 1.350 (sensitivity 54.2%, specificity 91.3%, accuracy 64.6%) for minimum ADCt ratio (Table 3) .
Step-up ROC analyses on the potential multifactorial models lead to an optimal logistic regression model including the four factors with 2-dimensional interaction: mean ADCt value and the minimum, maximum and mean ADCt ratio variables. The AUC of the combined four factors was 0.84 (Fig. 2) . We evaluated an optimal cut-off value for differentiation of high-grade gliomas from metastases of 0.716 (logistic regression fitted-value) which implies a sensitivity of 72.9%, a specificity of 82.6%, and an accuracy of 75.6% (Table 3 ). The optimal cut-off value, i.e., the logistic regression fitted optimal cut-off value of 0.716, can be interpreted as the probability of diagnosis of a highgrade glioma given the underlying model. Thus, using the given model for a new patient, a probability value of more than the cut-off value predicts a high-grade glioma, while a probability below the threshold suggests metastases. Table 4 shows the optimal model and the corresponding logistic regression results. All four main parameters are significant on the 5% level in this model and thus contribute to the prediction. The odds ratios show an increasing likehood of diagnosis of high-grade glioma versus metastases for each increase in ADC level.
Discussion
MR imaging is the standard neuroimaging technique for the detection and evaluation of brain tumors because it provides excellent soft tissue differentiation, accurately delineates their anatomic localization for operative planning and allows assessment of tumor response to therapy (1, 10). However, it does not provide information on cellularity, the true extent of the lesion and offers limited information regarding tumor type and grade (11Á13). Thus, there is a need for additional imaging modalities, such as DWI, which may aid in imaging the differentiation of brain tumor types. DWI sequences are specifically sensitive to cellular status, density, and microstructural organization (14) .
Our study showed that the minimum and mean of ADCt values and ADCt ratios of metastases were significantly lower than those in high-grade gliomas. However, other studies have found the mean ADC values at enhancing areas (15, 16) and peritumoral edema (15Á17) of metastases to be significantly higher than those in high-grade gliomas. Nevertheless, in the study of KRABBE et al. (16) diffusion was measured in a single axial slice sensitive to diffusion only along the cephalocaudal axis, and all of these studies have the limitation of including relatively small sample populations. Several authors (18, 19) found that the ADCs of glioblastomas and metastatic tumors could not be discriminated. BULAKBASI et al. (20) found that the normalized ADC ratios from metastatic tumor areas (equivalent to our mean ADCt ratio) were significantly lower than those of Note: t 0tumor; e0peritumoral edema; min0minimum; max0maximum; ADCt ratio 0ratio tumor/contralateral hemisphere; ADCe ratio0ratio peritumoral edema/contralateral hemisphere; ADCt/e ratio0ratio tumor/peritumoral edema. The significant P-values of the tumor-group differences are shown in bold in the column to the right.
high-grade astrocytomas, in agreement with our results, but the difference between other parameters (ADCt, ADCe) was not significant. In our study, the ADC values and ADC ratios for peritumoral edema did not differ significantly among patients with high-grade gliomas and metastases. Therefore, DWI was not useful in determining the presence of peritumoral neoplastic cell infiltration. This is in agreement with VAN WESTEN et al. (21), however is not consistent with a previous report (22) . In our study, the ADC values (ADCt) and the ADC ratios (ADCt ratio, ADCt/e ratio) of primary cerebral lymphomas were lower than those of highgrade gliomas; however, the difference between the two populations was not statistically significant, in disagreement with the results of other authors (18, 19, 23, 24 In the present study, the ADC values (ADCt, ADCe) and the ADC ratios (ADCt ratio, ADCe ratio, and ADCt/e ratio) did not differ significantly between high-grade gliomas and meningiomas, in according with the results observed by PROVENZALE et al. (6) and VAN WESTEN et al. (21) . However, some studies have demonstrated a significant difference in peritumoral ADC between low-grade meningiomas and high-grade gliomas (2), possibly reflecting the presence of tumor-infiltrated edema in gliomas, but this study only included six patients.
In our study, the ADC values and ADC ratios of the peritumoral edema did not differ significantly between metastases and meningiomas, which are in agreement with VAN WESTEN et al. (21) . This is in conflict with the results of a previous study (25) that Note: high-grade0high-grade gliomas; t 0tumor; e 0peritumoral edema; ADCt ratio0ratio tumor/contralateral hemisphere; ADCt/e0ratio tumor/peritumoral edema; min0minimum; max0maximum. Bold text indicates statistical significance on the 5% level.
Acta Radiol 2009 (6) found the ADC values of peritumoral edema were significantly higher in metastases than in meningiomas, suggesting that the traditional classification of peritumoral edema into purely vasogenic edema and infiltrative may not be sufficient.
Our results indicate that the ADC is not useful for differentiation between lymphomas and metastases; contrary to a study by YAMASAKI et al. (18), who found that the ADC of malignant lymphomas was lower than that of glioblastomas and metastatic tumors.
In the present study, the best-performing single parameter in differentiating high-grade gliomas from metastases was the minimum ADCt ratio. The specificity of this parameter in the determination of a high-grade glioma was 91.3%, indicating a high true-negative rate and low false-positive rate. Hence, if the minimum ADCt ratio is above 1.350, there is a high probability that the tumor will be a high-grade glioma. Conversely, when the minimum ADCt ratio is less than 1.350, the tumor is unlikely to be high-grade glioma. However, the relatively low sensitivity means that the truepositive rates are relatively low and false-negative are correspondingly high; in other words, some metastases will be falsely identified as high-grade gliomas. Combination of four parameters (step-up ROC analysis) provided the highest accuracy and the estimated ROC curve area was 0.84, indicating a very good test.
There are limitations to our study. The first limitation is that dexamethasone treatment can produce a moderate decline of the ADC values in areas with peritumoral edema independently of tumor type, whereas diffusion changes within the tumor are largely unaffected (26) . In the current study, dexamethasone treatment was given to 51% of patients with high-grade gliomas, 48% of patients with metastases, 60% of patients with lymphomas, and 50% of patients with meningiomas. Another limitation of this study is that we did not perform any precise stereotactic histopathologic correlation with the sites where the ADC values were measured.
In conclusion, ADC values and ADC ratios in peritumoral brain regions were not useful in determining the presence of peritumoral neoplastic cell infiltration. However, ADCt value and ADCt ratio (minimum and mean) may help in the differentiation of metastases from high-grade gliomas, although there is some overlap between ADCs of Note: t 0tumor; ADCt ratio0ratio tumor/contralateral hemisphere; min0minimum; max0maximum; CV0cut-off value; PPV: positive predictive value; NPV0negative predictive value; AUC 0area under the curve; AIC0Akaikes information criterion. *Logistic regression fitted value. Fig. 2 . ROC curves for mean ADC tumor, minimum ADC tumor ratio, maximum ADC tumor ratio, and mean ADC tumor ratio for differentiation between high-grade gliomas and metastases. these two brain tumors. Combining parameters from four factors model with two-dimensional interaction resulted in improved diagnostic accuracy.
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